After covering cardiovascular technologies for 14 years, it is rare that I find a new technology that might actually be ...
Heart failure (HF) is a prevalent yet silent epidemic, affecting 26 million people and costing global healthcare systems ...
The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
March 12, 2021 — Since early in the pandemic, COVID-19 has been associated with heart problems, including reduced ...
March 12, 2021 — Philips Healthcare announced the final, five-year results of two major randomized controlled trials ...
March 12, 2021 — A new review suggests that blood vessel damage and impaired oxygen delivery related to COVID-19 play a ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
March 12, 2021 — Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to ...
Intra-cardiac Echocardiography (ICE) uses catheter-based cardiac ultrasound array to image anatomy and devices inside ...
While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...
March 8, 2021 — University of Kansas Health System Cardiologist Ashley Simmons, M.D., knew there could and should be a ...
March 3, 2021 — Medtronic announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 3, 2021 — Impulse Dynamics recently announced that DEKRA Certification B.V., a global regulatory organization ...
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...
March 3, 2021 — Farapulse Inc. announced the first patients were treated in the ADVENT Trial, a U.S. Food and Drug ...
March 16, 2021
